112 related articles for article (PubMed ID: 8020629)
1. Hydroxyurea enhances 3'-azido-3'-deoxythymidine (AZT) cytotoxicity in human chronic myeloid leukemia models.
Tosi P; Visani G; Ottaviani E; Tura S; Darnowski JW
Eur J Haematol; 1994 May; 52(5):291-5. PubMed ID: 8020629
[TBL] [Abstract][Full Text] [Related]
2. Synergistic cytotoxicity of AZT plus alpha and gamma interferon in chronic myeloid leukemia cell line K562.
Tosi P; Visani G; Ottaviani E; Gamberi B; Cenacchi A; Tura S
Eur J Haematol; 1993 Oct; 51(4):209-13. PubMed ID: 8243609
[TBL] [Abstract][Full Text] [Related]
3. In vitro toxicity of A 3'-azido-3'-deoxythymidine and hydroxyurea combination on normal myeloid progenitors.
Lerza R; Castello G; Ballarino P; Mela GS; Tredici S; Arboscello E; Mencoboni M; Pannacciulli I
Anticancer Res; 1998; 18(4A):2755-8. PubMed ID: 9703941
[TBL] [Abstract][Full Text] [Related]
4. Combination studies with 3'-azido-3'-deoxythymidine (AZT) plus ICI D1694. Cytotoxic and biochemical effects.
Pressacco J; Erlichman C
Biochem Pharmacol; 1993 Dec; 46(11):1989-97. PubMed ID: 8267649
[TBL] [Abstract][Full Text] [Related]
5. Synergistic antiproliferative effect of interferon alpha and azidothymidine in chronic myelogenous leukemia.
Estrov Z; Talpaz M; Chou TC; Kurzrock R; Blake M; Gutterman JU
Leukemia; 1991 Feb; 5(2):101-7. PubMed ID: 2020193
[TBL] [Abstract][Full Text] [Related]
6. 2'-Deoxycytidine protects normal human bone marrow progenitor cells in vitro against the cytotoxicity of 3'-azido-3'-deoxythymidine with preservation of antiretroviral activity.
Bhalla K; Birkhofer M; Li GR; Grant S; MacLaughlin W; Cole J; Graham G; Volsky DJ
Blood; 1989 Nov; 74(6):1923-8. PubMed ID: 2572282
[TBL] [Abstract][Full Text] [Related]
7. Emodin and AZT synergistically inhibit the proliferation and induce the apoptosis of leukemia K562 cells through the EGR1 and the Wnt/β‑catenin pathway.
Ma W; Liu F; Yuan L; Zhao C; Chen C
Oncol Rep; 2020 Jan; 43(1):260-269. PubMed ID: 31746437
[TBL] [Abstract][Full Text] [Related]
8. The effect of recombinant human granulocyte-macrophage colony-stimulating factor (rGM-CSF) on 3'-azido-3'-deoxythymidine (AZT)-mediated biochemical and cytotoxic effects on normal human myeloid progenitor cells.
Bhalla K; Birkhofer M; Grant S; Graham G
Exp Hematol; 1989 Jan; 17(1):17-20. PubMed ID: 2783247
[TBL] [Abstract][Full Text] [Related]
9. 3'-Azido-3'-deoxythymidine cytotoxicity and metabolism in the human colon tumor cell line HCT-8.
Darnowski JW; Goulette FA
Biochem Pharmacol; 1994 Nov; 48(9):1797-805. PubMed ID: 7980649
[TBL] [Abstract][Full Text] [Related]
10. Azidothymidine-induced cytotoxicity and incorporation into DNA in the human colon tumor cell line HCT-8 is enhanced by methotrexate in vitro and in vivo.
Tosi P; Calabresi P; Goulette FA; Renaud CA; Darnowski JW
Cancer Res; 1992 Aug; 52(15):4069-73. PubMed ID: 1638518
[TBL] [Abstract][Full Text] [Related]
11. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells.
Gallicchio VS; Hughes NK; Hulette BC; Noblitt L
J Leukoc Biol; 1991 Dec; 50(6):580-6. PubMed ID: 1940611
[TBL] [Abstract][Full Text] [Related]
12. Surmounting Cytarabine-resistance in acute myeloblastic leukemia cells and specimens with a synergistic combination of hydroxyurea and azidothymidine.
Levin M; Stark M; Berman B; Assaraf YG
Cell Death Dis; 2019 May; 10(6):390. PubMed ID: 31101804
[TBL] [Abstract][Full Text] [Related]
13. Cellular pharmacology of 3'-azido-3'-deoxythymidine with evidence of incorporation into DNA of human bone marrow cells.
Sommadossi JP; Carlisle R; Zhou Z
Mol Pharmacol; 1989 Jul; 36(1):9-14. PubMed ID: 2747633
[TBL] [Abstract][Full Text] [Related]
14. Antiviral nucleoside toxicity in canine bone marrow progenitor cells and its relationship to drug permeation.
Chan TC; Boon GD; Shaffer L; Redmond R
Eur J Haematol; 1992 Aug; 49(2):71-6. PubMed ID: 1327866
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic and biochemical implications of combining AZT and AG-331.
Pressacco J; Mitrovski B; Erlichman C
Cancer Chemother Pharmacol; 1995; 35(5):387-90. PubMed ID: 7850919
[TBL] [Abstract][Full Text] [Related]
16. 5-Fluorouracil enhances azidothymidine cytotoxicity: in vitro, in vivo, and biochemical studies.
Brunetti I; Falcone A; Calabresi P; Goulette FA; Darnowski JW
Cancer Res; 1990 Jul; 50(13):4026-31. PubMed ID: 2354452
[TBL] [Abstract][Full Text] [Related]
17. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
Scheding S; Media JE; Nakeff A
Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of CFU-GM from normal human bone marrow and leukaemic clonogenic cells (CFU-L) from blood of patients with myelogenous leukaemia to 3'-deoxy-3'-fluorothymidine in comparison to 3'-azido-3'-deoxythymidine.
Blau IW; Elstner E; Waechter M; Ihle R; von Janta-Lipinski M; Langen P
Blut; 1989 Nov; 59(5):455-7. PubMed ID: 2819251
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
Zhang GS; Liu DS; Dai CW; Li RJ
Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
[TBL] [Abstract][Full Text] [Related]
20. Cellular pharmacodynamics and plasma pharmacokinetics of parenterally infused hydroxyurea during a phase I clinical trial in chronic myelogenous leukemia.
Gandhi V; Plunkett W; Kantarjian H; Talpaz M; Robertson LE; O'Brien S
J Clin Oncol; 1998 Jul; 16(7):2321-31. PubMed ID: 9667246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]